TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BDSX

Biodesix Inc

Healthcare · Diagnostics & Research

29.10$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Biodesix Inc (BDSX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 27 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement BDSX
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
13 15 15 18 18 20 18 20 22 29 26 27 103
3.2 3.4 3.2 3.9 4.2 4.3 3.7 4.0 4.1 4.9 4.2 4.8 18
10 11 12 14 14 16 14 16 18 24 21 22 85
1.9 1.9 2.0 2.6 2.5 2.4 2.9 3.3 3.0 2.9 3.3 3.1 12
15 35 21 20 20 20 20 22 22 23 24 24 93
17 18 23 22 23 23 23 26 25 26 28 27 106
-7.2 -6.8 -11 -8.2 -8.6 -6.6 -9.1 -9.7 -7.0 -2.0 -6.2 -5.4 -21
2.4 2.3 2.5 1.9 2.0 1.8 1.7 1.9 2.1 2.1 2.0 2.0 8.1
-11 -9.1 -14 -11 -10 -8.3 -11 -11 -8.7 -4.0 -7.8 -7.3 -28
2.4 -3.2 1.3 – -1.4 -1.3 – – – – – – –
-11 -9.1 -14 -11 -10 -8.3 -11 -11 -8.7 -4.0 -7.8 -7.3 -28
-7.3 -5.5 -9.8 -7.6 -6.8 -5.1 -8.0 -8.2 -5.3 -0.5 -4.4 -4.1 -14

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?